Last reviewed · How we verify

LiquiTears — Competitive Intelligence Brief

LiquiTears (LiquiTears) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Artificial tear / Lubricating ophthalmic solution. Area: Ophthalmology.

marketed Artificial tear / Lubricating ophthalmic solution Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

LiquiTears (LiquiTears) — Chakshu Research, Inc.. LiquiTears is an artificial tear solution that lubricates and protects the ocular surface to relieve dry eye symptoms.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
LiquiTears TARGET LiquiTears Chakshu Research, Inc. marketed Artificial tear / Lubricating ophthalmic solution
Tears Naturale II Ophthalmic Solution Tears Naturale II Ophthalmic Solution ORA, Inc. marketed Artificial tear / Lubricating ophthalmic solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Artificial tear / Lubricating ophthalmic solution class)

  1. Chakshu Research, Inc. · 1 drug in this class
  2. ORA, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). LiquiTears — Competitive Intelligence Brief. https://druglandscape.com/ci/liquitears. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: